Pfizer vs. AbbVie: Higher Yield and Cheaper Valuation Give One the Clear Edge
Pfizer offers a higher dividend yield and a cheaper valuation, while AbbVie brings stronger earnings momentum and a history of dividend growth.
Barchart ·